You have 9 free searches left this month | for more free features.

Indonesian healthy female

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Healthy Trial in Edegem (BI 765845, Placebo)

Completed
  • Healthy
  • BI 765845
  • Placebo
  • Edegem, Belgium
    SGS Life Science Services - Clinical Research
Nov 27, 2023

Healthy Trial in Christchurch (LTG-001, Placebo)

Not yet recruiting
  • Healthy
  • Christchurch, New Zealand
    Clinical Research Unit
Sep 21, 2023

Healthy Female Participants Trial in Brooklyn (Zibotentan, EE/LNG)

Not yet recruiting
  • Healthy Female Participants
  • Brooklyn, Maryland
    Research Site
Aug 16, 2022

Healthy Trial in Beijing (BI 1015550)

Recruiting
  • Healthy
  • BI 1015550
  • Beijing, China
    Peking Union Medical College Hospital
Jan 26, 2023

Vasculitis, Systemic Lupus Erythematosus (SLE) Trial in Allschwil (CCX168, Placebo)

Completed
  • Vasculitis
  • Systemic Lupus Erythematosus (SLE)
  • Allschwil, Switzerland
    Covance Clinical Research Unit (CRU) AG
Aug 2, 2023

Drug Use Trial in Jakarta Pusat (Furosemide 40 mg, Lasix® 40 mg Tablet)

Completed
  • Drug Use
  • Furosemide 40 mg
  • Lasix® 40 mg Tablet
  • Jakarta Pusat, DKI Jakarta, Indonesia
    PT Pharma Metric Labs
Aug 4, 2021

First in Man Study to Evaluate Initial Safety Trial in Leeds (GL-0719, Placebo)

Recruiting
  • First in Man Study to Evaluate Initial Safety
  • Leeds, United Kingdom
    Labcorp Clinical Research Unit Ltd
Sep 9, 2022

Healthy Trial in Denpasar, Singaraja, Tabanan (Yakult®, Placebo)

Completed
  • Healthy
  • Yakult®
  • Placebo
  • Denpasar, Badung, Indonesia
  • +2 more
Apr 1, 2022

Type 2 Diabetes, Healthy Subjects Trial in Miami (sotagliflozin (SAR439954))

Completed
  • Type 2 Diabetes Mellitus
  • Healthy Subjects
  • sotagliflozin (SAR439954)
  • Miami, Florida
    Investigational Site Number 8400001
Apr 21, 2022

Healthy Subjects Trial in Baltimore (KBP-7072, Placebo)

Recruiting
  • Healthy Subjects
  • Baltimore, Maryland
    Parexel International - Early Phase Clinical Unit
Aug 16, 2022

Healthy Aging Trial (Jarlsberg cheese)

Not yet recruiting
  • Healthy Aging
  • Jarlsberg cheese
  • (no location specified)
Jun 27, 2022

Healthy Trial in Groningen (Nipocalimab, Placebo)

Completed
  • Healthy
  • Groningen, Netherlands
    PRA Health Sciences
Jul 5, 2022

Healthy Volunteers, Hepatic Impairment Trial (GP681)

Not yet recruiting
  • Healthy Volunteers
  • Hepatic Impairment
  • (no location specified)
Apr 4, 2023

Chronic Pain Trial in Berlin (MEDI0618, Placebo)

Recruiting
  • Chronic Pain
  • Berlin, Germany
    Research Site
Jan 26, 2023

Healthy Subjects Trial (Camizestrant, Itraconazole)

Completed
  • Healthy Subjects
  • Harrow, United Kingdom
    Research Site
Jan 5, 2023

Healthy Volunteers Trial in Bei'jing (fezolinetant)

Completed
  • Healthy Volunteers
  • Bei'jing, China
    Site CN86001
Apr 15, 2022

Mass Balance Recovery Trial in Baltimore ([14C]-D-0502)

Active, not recruiting
  • Mass Balance Recovery
  • Baltimore, Maryland
    Site Location
May 19, 2022

ER+ Breast Cancer Trial in Jakarta (Tamoxifen dose adjustment)

Completed
  • ER+ Breast Cancer
  • Tamoxifen dose adjustment
  • Jakarta, DKI Jakarta, Indonesia
    MRCCC Siloam Hospital Semanggi
Aug 4, 2021

Healthy Trial in Merksem (JNJ-67953964, Placebo)

Completed
  • Healthy
  • Merksem, Belgium
    Clinical Pharmacology Unit
Jul 20, 2022

Healthy Subjects Trial in Baltimore (Fezolinetant)

Completed
  • Healthy Subjects
  • Baltimore, Maryland
    Parexel
Feb 10, 2022

Healthy Trial in Mannheim (BI 1819479, BI matching )

Recruiting
  • Healthy
  • BI 1819479
  • BI matching placebo
  • Mannheim, Germany
    CRS Clinical Research Services Mannheim GmbH
Aug 5, 2022

Healthy Subjects Trial in Dilworth (FL-101-Intravenous, FL-101-Subcutaneous)

Completed
  • Healthy Subjects
  • Dilworth, Minnesota
    Axis Clinicals
May 29, 2022

Healthy Trial in Cypress, South Miami, San Antonio (Imlunestrant, Repaglinide, Omeprazole)

Completed
  • Healthy
  • Cypress, California
  • +2 more
Nov 23, 2022

Obesity, Overweight, Binge Eating Trial run by the NICHD (Attention Bias Retraining, Booster Attention Retraining)

Recruiting
  • Obesity
  • +3 more
  • Attention Bias Retraining
  • Booster Attention Retraining
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 25, 2023

Diabetes Trial in Gières (Sotagliflozin (SAR439954), Mefenamic acid)

Completed
  • Diabetes Mellitus
  • Sotagliflozin (SAR439954)
  • Mefenamic acid
  • Gières, France
    Investigational site 250001
Apr 21, 2022